Related Experiment Video

Updated: Jul 7, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

[Platelet response to aspirin and clopidogrel. Biochemical evaluation, clinical impact, and pharmacological

O Morel1, P Ohlmann, P Bareiss

  • 1Hôpital de Hautepierre, fédération de cardiologie des hôpitaux universitaires de Strasbourg. Oliver.Morel@chru-strasbourg.fr

Archives Des Maladies Du Coeur Et Des Vaisseaux
|January 29, 2008
PubMed

Insights

Determining platelet responsiveness is crucial for managing atherothrombosis, especially after percutaneous coronary interventions. Current platelet function assays lack standardization, but new point-of-care tests may offer solutions.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Pharmacology

Background:

  • Platelets play a key role in atherothrombosis, contributing to thrombotic and inflammatory responses.
  • Enhanced platelet aggregation negatively impacts clinical outcomes following percutaneous coronary interventions.
  • Accurate and practical platelet function assays are not widely available, and standardized definitions for "low-responders" are lacking.

Purpose of the Study:

  • To highlight the clinical significance of assessing platelet responsiveness.
  • To discuss the limitations of current platelet function testing methods.
  • To explore potential solutions for monitoring platelet function and managing "low-responders".

Main Methods:

  • Review of existing literature on platelet function assays and their clinical implications.
  • Discussion of light transmission platelet aggregometry as the current "gold-standard".
  • Exploration of emerging "point-of-care" platelet assays and their validation needs.

Main Results:

  • Light transmission platelet aggregometry is the established standard but has limitations.
  • Point-of-care assays show promise but require further clinical validation.
  • Platelet monitoring is recommended for high-risk patients per ACC/AHA guidelines.

Conclusions:

  • Optimizing antiplatelet therapy requires accurate assessment of platelet responsiveness.
  • Dose escalation of clopidogrel or switching to prasugrel can improve outcomes in "low-responders".
  • Further development and validation of platelet function assays are essential for clinical practice.

More Related Videos

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.